California Public Employees Retirement System’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-40,600
Closed -$233K – 1678
2021
Q1
$233K Sell
40,600
-3,817
-9% -$28.3K ﹤0.01% 3319
2020
Q4
$397K Buy
44,417
+2,917
+7% +$31.1K ﹤0.01% 3038
2020
Q3
$483K Buy
41,500
+1,300
+3% +$18.9K ﹤0.01% 2790
2020
Q2
$644K Buy
40,200
+29,867
+289% +$331K ﹤0.01% 2528
2020
Q1
$62K Buy
+10,333
New +$95.5K ﹤0.01% 3228

Other funds holding AUTL

California Public Employees Retirement System's AUTL Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Autolus Therapeutics (AUTL) in Q2 2021, closing a stake of 40,600 shares — an estimated $233K sold.

California Public Employees Retirement System first reported a position in AUTL in Q1 2020 and held it in 5 quarters. The position peaked at $644K in Q2 2020. 69 funds tracked by Wall St. Rank hold AUTL as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Autolus Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 40,600 Autolus Therapeutics shares in Q2 2021, an estimated $233K.
  • California Public Employees Retirement System first reported a position in Autolus Therapeutics in Q1 2020 and held it in 5 quarters.
  • California Public Employees Retirement System's Autolus Therapeutics position peaked at $644K in Q2 2020.
  • 69 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.